Connect with us

Hi, what are you looking for?

Investing

Radiopharm Theranostics (RAD:AU) has announced RAD 202 receives approval to start Phase 1 therapeutic trial Download the PDF here. This post appeared first on...

Investing

AgTech Company highlights recent 100% purchase of Hemp Carbon Standard platform to advance industrial hemp carbon credits global market opportunity Hempalta Corp. (TSXV: HEMP)...

Investing

Clothed in geopolitical uncertainty, 2023 has been a bumpy ride for investors. Central banks began raising interest rates early in 2022 to help get...

Investing

The NASDAQ Biotechnology Index (INDEXNASDAQ:NBI) has slowly tracked downward over the course of 2023 in response to the high levels of volatility seen across...

Investing

Carbonxt Group Limited (Carbonxt or the Company) is pleased to announce that it has successfully raised$0.6m (before costs) through the placement (“the Placement”) of...

Enter Your Information Below To Receive Free Trading Ideas, Latest News And Articles.






    Your information is secure and your privacy is protected. By opting in you agree to receive emails from us. Remember that you can opt-out any time, we hate spam too!

    Disclaimer: aimyourdeals.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.


    Copyright © 2023 aimyourdeals.com